美国监管机构批准一种更廉价的艾滋病预防针剂，给世界上一些最贫穷的国家带来了希望，这些国家中许多正因西方援助削减而陷入困境。
US regulators’ approval of a cheaper HIV shot has lifted hopes in some of the world’s poorest countries, many of which are reeling from Western aid cuts.
据美联社报道，FDA对通用版来那卡韦给予暂时批准，这是一种每年注射两次、有助于预防艾滋病毒感染的药物。这一举措将使该药物以每人每年40美元的价格在120个低收入和中等收入国家供应。
The FDA granted tentative approval of a generic lenacapavir, a twice-a-year injection that helps prevent HIV infection. The move will make the drug available for $40 per person a year in 120 low- and middle-income countries, the Associated Press reported.
华盛顿削减对非洲部分艾滋病预防项目的资助，导致当地工作陷入停滞，引发担忧：非洲大陆可能出现数十万例额外的艾滋病相关死亡。
Washington’s funding cuts to some HIV-prevention programs in Africa left efforts there floundering, sparking fears that the continent could see hundreds of thousands of additional deaths from AIDS.
一位全球健康倡导者表示，这种平价药物的大规模推广有助于“终结艾滋病流行”。
A large-scale rollout of the affordable drug could help “bring an end to the HIV epidemic,” a global health advocate said.